K. K. Yoneten Et Al. , "Decreased serum levels of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer," CANCER BIOMARKERS , vol.34, no.1, pp.67-76, 2022
Yoneten, K. K. Et Al. 2022. Decreased serum levels of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer. CANCER BIOMARKERS , vol.34, no.1 , 67-76.
Yoneten, K. K., Kasap, M., Arga, K. Y., Akpinar, G., & Utkan, N. Z., (2022). Decreased serum levels of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer. CANCER BIOMARKERS , vol.34, no.1, 67-76.
Yoneten, Kubra Et Al. "Decreased serum levels of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer," CANCER BIOMARKERS , vol.34, no.1, 67-76, 2022
Yoneten, Kubra K. Et Al. "Decreased serum levels of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer." CANCER BIOMARKERS , vol.34, no.1, pp.67-76, 2022
Yoneten, K. K. Et Al. (2022) . "Decreased serum levels of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer." CANCER BIOMARKERS , vol.34, no.1, pp.67-76.
@article{article, author={Kubra Karaosmanoglu Yoneten Et Al. }, title={Decreased serum levels of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer}, journal={CANCER BIOMARKERS}, year=2022, pages={67-76} }